Analystreport

Milestone Pharmaceuticals Inc. (NASDAQ: MIST) was upgraded by analysts at Oppenheimer Holdings Inc. from a "market perform" rating to an "outperform" rating.

Milestone Pharmaceuticals Inc. - Common Shares  (MIST) 
Last milestone pharmaceuticals inc. - common shares earnings: 3/6 07:00 am Check Earnings Report